Inhibition, Psychological: Clinical Trials

85 trials for Inhibition, Psychological, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 15 unknown, 9 recruiting, 6 active not recruiting. 53 Not applicable, 10 Phase 1, 4 Phase 2, 4 Phase 3, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable53Completed 25, Unknown 10, Recruiting 8, Active not recruiting 4, Not yet recruiting 3, Terminated 2, Withdrawn 1
Phase 110Completed 7, Unknown 2, Terminated 1
Phase 24Completed 2, Active not recruiting 1, Unknown 1
Phase 34Completed 3, Active not recruiting 1
Phase 43Unknown 2, Terminated 1
Early Phase 11Unknown 1

Follow Inhibition, Psychological: new trials by email Literature Review of Inhibition, Psychological trials Research Report on Inhibition, Psychological

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
Soterix 1x1 tES mini-CT - Bipolar Disorder, Bipolar and Related Disorders
Not applicableNot yet recruitingVA Office of Research and Development1382027-06-012026-09-28
Tiny Heroes Compared to Treatment as Usual to Decrease and Prevent Anxiety Problems in Young Children - a Randomized Controlled Study
Parent-directed online cognitive behavioral therapy, Treatment as Usual (TAU) - Anxiety Mild to Moderate, Inhibition (Psychology)
Not applicableNot yet recruitingKarolinska Institutet3502026-10-152026-10-13
Active Breaks and Executive Function in Scholars
Active Break - Creativity, Executive Function (Cognition)
Not applicableRecruitingUniversitat Jaume I1142026-03-262026-04-20
Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
Five Digits Test - Autism, ADHD
RecruitingUmeå University1502026-01-212026-04-15
Comprehensive Therapeutic Program For People With Multiple Sclerosis
Outpatient physiotherapy, group psychotherapy - Multiple Sclerosis, Neurorehabilitation
Not applicableNot yet recruitingCharles University, Czech Republic262025-12-052025-12-01
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
Short-Chain Fatty Acid Colon-Delivery Capsules, Placebo capsules, Lipopolysaccharide (LPS) - Endotoxemia, Inflammation
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven562025-10-242026-07-20
Cutaneous Silent Period-Based Comparison of DRG-PRF and TFESI in Lumbar Radicular Pain
Radiofrequency, Transforaminal Epidural Steroid Injection - Lumbar Radicular Pain, Spinal
Not applicableActive not recruitingahmet başarı542025-07-082025-08-05
The Effects of 8-week Resistance and Aerobic Exercise on Anxiety, Depression, Sleep, Inhibitory Control in Young Adults With Smartphone Overdependence
resistance exercise, aerobic exercise, Control (placebo) - Exercise, Smartphone Addiction
Not applicableCompletedUniversity of Seoul362025-01-062025-02-27
Inhibitory Control Training and iTBS for Excess Weight: Behavioral and Brain Changes (InhibE).
iTBS of the left DLPFC, iTBS of the vertex, Inhibitory control training - Overweight and Obesity, Inhibition, Psychological
Not applicableRecruitingRaquel Vilar López1412024-11-302025-02-14
Inhibitory Control Training for Excess Weight: Behavioural, Cognitive and Anthropometric Changes
Inhibitory control training, Placebo Inhibitory control training - Overweight and Obesity, Inhibition, Psychological
Not applicableRecruitingRaquel Vilar López542024-11-302025-03-25
An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans
Contour Search Task, Stop signal Task, Useful field of View - Eye Movements, Attention
Not applicableRecruitingUniversity of Colorado, Denver2252024-09-152026-02-20
NEUROPSYCHOLOGICAL REHABILITATION FOR ALCOHOL USE DISORDERS
Neuropsychological rehabilitation, Weekly therapeutic groups - Alcohol Use Disorder Cognitive Decline
Not applicableActive not recruitingUniversity of Lisbon482024-09-152025-04-18
Brain Connectivity Between Networks Implied in Inhibition and Cue-reactivity in Alcohol Use Disorder
Go-Nogo-task during functional magnetic resonance imaging, Resting-state functional magnetic resonance imaging - Alcohol Use Disorder
CompletedUniversity of Bern592024-05-012025-11-25
Transcranial Magnetic Stimulation and Inhibitory Control Training to Reduce Binge Eating: Brain and Behavioral Changes
Active iTBS of the DLPFC, Active iTBS of the vmPFC, iTBS of the vertex (sham) - Binge Eating, Inhibition, Psychological
Not applicableRecruitingRaquel Vilar López1502024-04-292025-03-25
Physical Activity on Motor Competence, Cognitive Function and Mood in Adolescents
"Coordinative-Based Physical Activity Practices" training group - Healthy, Adolescent
Not applicableCompletedNamik Kemal University402024-04-152025-08-08
Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome
Auricular vagal neuromodulation therapy (aVNT), Sham Auricular vagal neuromodulation therapy (aVNT) - Prader-Willi Syndrome
Not applicableRecruitingUniversity of Bordeaux242023-11-222024-12-06
Janus Kinase Inhibition in Granuloma Annulare
Abrocitinib 200 mg - Granuloma Annulare
Phase 2CompletedWilliam Damsky102023-10-272026-10-07
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
Neuropsychological assessment, Neurological assessment, Cognitive task - Parkinson Disease
Not applicableActive not recruitingInstitut National de la Santé Et de la Recherche Médicale, France902023-05-032026-10-23
Rate of Torque Development in Adolescents With Osgood-Schlatter
Rate of torque development testing of knee flexors and knee extensors using a fixated handheld dynamometer (MicroFet 2, Hoggan, Scientific L.L.C., Salt Lake City, USA), sampling rate of 100hz) - Osgood-Schlatter Disease
CompletedHvidovre University Hospital262023-02-282024-01-09
Attention Modulation of Local and Global Inhibition Mechanisms
experience 1 "The negative priming task", experience 2 "Stop signal task", experience 3 "Anti-saccades" - Optical Phenomena
Not applicableRecruitingHospices Civils de Lyon1202022-11-262026-01-20

Showing 20 of 85. Sign in to see all of them.

Narrower conditions

Alcoholism (7)  ·  Attention Deficit Disorder with Hyperactivity (4)  ·  Impulsive Behavior (4)  ·  Motor Activity (4)  ·  Multiple Sclerosis (4)  ·  Obesity (3)  ·  Anxiety Disorders (2)  ·  Atherosclerosis (2)  ·  Bulimia (2)  ·  Dyslipidemias (2)  ·  Feeding Behavior (2)  ·  Hypercholesterolemia, Autosomal Dominant, 3 (2)  ·  Hyperlipidemias (2)  ·  Inflammation (2)

Broader conditions

Behavior (84)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Nervous System Diseases (22)  ·  Mental Disorders (20)  ·  Signs and Symptoms (18)  ·  Neurologic Manifestations (11)  ·  Chemically-Induced Disorders (8)  ·  Pathologic Processes (8)  ·  Alcohol-Related Disorders (7)  ·  Central Nervous System Diseases (7)  ·  Neurodevelopmental Disorders (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Substance-Related Disorders (7)  ·  Brain Diseases (6)  ·  Cardiovascular Diseases (6)

Interventions

Exercise (5)  ·  Dipyrone (2)  ·  Neuropsychological Tests (2)  ·  Transcranial Direct Current Stimulation (2)  ·  Transcranial Magnetic Stimulation (2)  ·  anacetrapib (2)  ·  evolocumab (2)  ·  AZD1390 (1)  ·  BaseLine dental cement (1)  ·  Cannabidiol (1)  ·  Carbamazepine (1)  ·  Control Groups (1)  ·  Endotoxins (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  INCB039110 (1)

Sponsors

Charles University, Czech Republic (4)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  Raquel Vilar López (3)  ·  5 Santé (2)  ·  Amgen (2)  ·  Brugmann University Hospital (2)  ·  Incyte Corporation (2)  ·  Nanyang Technological University (2)  ·  University Hospital, Basel, Switzerland (2)  ·  University of Bern (2)  ·  Universitätsklinikum Hamburg-Eppendorf (2)  ·  Affiris AG (1)  ·  AstraZeneca (1)  ·  Auburn University (1)  ·  Brigham and Women's Hospital (1)

Countries

United States (27)  ·  France (8)  ·  Spain (7)  ·  United Kingdom (7)  ·  Switzerland (6)  ·  Italy (5)  ·  Belgium (4)  ·  Canada (4)  ·  Czechia (3)  ·  Germany (3)  ·  Portugal (3)  ·  Turkey (Türkiye) (3)  ·  Austria (2)  ·  Singapore (2)  ·  South Korea (2)

Top investigators

Achim Schneeberger, MD (1)  ·  Adele Diamond, Ph.D. (1)  ·  Ahmet Basari, Pain Specialist, Neurologist (1)  ·  Anissa Ramadhani (1)  ·  Anthony Chalmers (1)  ·  Boushra Dalile, PhD (1)  ·  Bradley Maron, MD (1)  ·  Brandon Imber (1)  ·  Brant Hasler, PhD (1)  ·  Bruno Lenne (1)  ·  Carly J Leonard, Phd (1)  ·  Casey S Gilmore, PhD (1)  ·  Cristina Ribeiro, PhD (1)

Results publications

PMID 21389338, PMID 23218805, PMID 25195081, PMID 28527788, PMID 33078867, PMID 10408541, PMID 12665406, PMID 12919862, PMID 14506711, PMID 14964588, PMID 15026491, PMID 16108583, PMID 16140191, PMID 16636792, PMID 19177542, PMID 19378414, PMID 20011221, PMID 20489392, PMID 20492580, PMID 21697448, PMID 21796541, PMID 21810782, PMID 22180633, PMID 22623677, PMID 22696435, PMID 23604335, PMID 23658775, PMID 24273711, PMID 24677429, PMID 24825952, PMID 25395111, PMID 25459105, PMID 25878272, PMID 26836515, PMID 26874269, PMID 28087843, PMID 28179221, PMID 28647437, PMID 28702504, PMID 28847206, PMID 29269306, PMID 29359066, PMID 29746911, PMID 30579387, PMID 30993594, PMID 31277683, PMID 31331193, PMID 32268367, PMID 32393252, PMID 32970918

NIH funding

2015 (3), 2017 (2), 2018 (1), 2019 (1), 2023 (1), 2025 (1), F32MH115530 (1), K23DA019522 (1), P30DK056350 (1), P50DA046346 (1), R15EY035056 (1)